ESMO GI cancers 2015

To be presented Sat 4th July:

Presentation of selected abstract
SIRFLOX: Randomized trial comparing first-line mFOLFOX6 ± bevacizumab versus mFOLFOX6 + selective internal radiation therapy (SIRT) ± bevacizumab in patients with metastatic colorectal cancer (mCRC) – analysis by presence or absence of extra-hepatic metastases and bevacizumab treatment
Guy van Hazel, et al., O-019ESMO

Looks like we will be seeing some subgroup analysis data! Monday 6th could be fun